Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 May;80(3):F174-7.
doi: 10.1136/fn.80.3.f174.

Randomised controlled trial of cisapride in preterm infants

R J McClure  1 , J H Kristensen, A Grauaug
Affiliations
Clinical Trial

Randomised controlled trial of cisapride in preterm infants

R J McClure et al. Arch Dis Child Fetal Neonatal Ed. 1999 May.

Abstract

Aim: To determine the effect of cisapride on gastrointestinal motility in preterm infants.

Methods: Cisapride (0.2 mg/kg, 8 hourly ) or placebo was given first for seven days in a double blind randomised crossover study of 10 preterm infants. Gastrointestinal motility was assessed on day 3 of each treatment. The half gastric emptying time (GET1/2) was determined by using ultrasonography to measure the decrease in the gastric antral cross sectional area after a feed. The whole gastrointestinal transit time (WGTT) was assessed by timing the transit of carmine red through the gut. Treatments were compared using the Wilcoxon matched pairs signed ranks test.

Results: Median (range) birthweight was 1200 (620, 1450) g and postconceptional age 33 (29, 34) weeks at recruitment. GET1/2 was significantly longer during cisapride treatment than during placebo; the median of the differences (95% confidence interval) was 19.2 (11, 30 minutes, p=0.008). WGTT was also longer during cisapride treatment, but the difference was not significant; the median of the differences was 11(-18, 52 hours, p=0.1).

Conclusions: Cisapride delays gastric emptying and may delay WGTT in preterm infants. Its use to promote gastrointestinal motility in this group cannot be recommended.

PubMed Disclaimer

Comment in

  • Randomised controlled trial of cisapride in preterm infants.
    Vandenplas Y. Vandenplas Y. Arch Dis Child Fetal Neonatal Ed. 2000 Jul;83(1):F75. doi: 10.1136/fn.83.1.f74b. Arch Dis Child Fetal Neonatal Ed. 2000. PMID: 10917722 Free PMC article. No abstract available.
  • The use of cisapride in neonates.
    Davies MW. Davies MW. Arch Dis Child Fetal Neonatal Ed. 2000 Jul;83(1):F75. doi: 10.1136/fn.83.1.f74c. Arch Dis Child Fetal Neonatal Ed. 2000. PMID: 10917723 Free PMC article. No abstract available.

References

    1. Eur J Clin Pharmacol. 1992;43(2):121-4 - PubMed
    1. Scand J Gastroenterol. 1992 Sep;27(9):799-804 - PubMed
    1. Arch Dis Child. 1993 Jul;69(1 Spec No):32-6 - PubMed
    1. Am J Physiol. 1994 Feb;266(2 Pt 1):G230-8 - PubMed
    1. Ann Pharmacother. 1994 Apr;28(4):488-500 - PubMed

Publication types